Our Board
Our Board of Directors brings deep experience in medical device development, commercialization, and healthcare investing to Olympic Ophthalmics.
Immanuel Thangaraj
Chief Executive Officer
Immanuel Thangaraj is a founding investor in Olympic Ophthalmics and has served as Chief Executive Officer since [year]. He has more than 30 years of experience in healthcare investing, operations, and company building. He began his career at ARCH Venture Partners and served as a Managing Director at Essex Woodlands Health Ventures for over 20 years. He was an early investor and board member of TearScience, acquired by Johnson & Johnson. He is Chief Executive Officer of Serene LLC and Co-Founder and Chairman of Jurna, Inc. He has led more than 20 products through FDA approval or clearance across device and therapeutic categories. He is a long-standing member of the Council of the Booth School of Business and the Visiting Committee of the College at the University of Chicago. He holds a B.A. and an M.B.A. from the University of Chicago.
Louis Cannon
Dr. Louis Cannon is a founding investor of Olympic Ophthalmics, as well as founder and senior managing director at BioStar Capital and the BioStar Ventures Funds. He is also founder and President of the Cardiac and Vascular Research Center of Northern Michigan and has been repeatedly honored as one of “America’s Top Interventional Cardiologists.” A previous Judah Folkman scholar in residence, Louis has authored hundreds of articles for medical publications and has served on the advisory boards for Fortune 500 companies such as Medtronic, Abbott, Boston Scientific, Johnson and Johnson, and Covidien, as well as many early developing medical technology companies. He recently served on the public Board of Directors of Corindus (CVRS: NYSE), acquired by Siemens Healthineers (OTC: SMMNY) which had over a 500% increase in market cap over 2 years since his tenure on the board.
